Total Pancreatectomy With Islet Cell Auto-Transplantation: Update and Outcomes From Major Centers
- 180 Downloads
Chronic pancreatitis is the result of irreversible damage to pancreatic acinar cells, and can result in debilitating chronic pain for patients. Treatment centers on pain relief, often with chronic narcotic use. Surgical therapy consists of both resection procedures to remove affected pancreatic parenchyma and drainage procedures to facilitate drainage of the main pancreatic duct. Total pancreatectomy historically was utilized in extreme cases due to the brittle glucose control that followed from the total loss of islet cells. Total pancreatectomy with islet cell auto-transplantation (TP-AIT) is gaining in popularity due to the maintenance of beta cell mass and the ability of patients to potentially be insulin independent post-operatively. TP-AIT is very helpful in the treatment of pain for patients with chronic pancreatitis. The overall majority of patients have an improvement in pain and quality-of-life scores. AIT also allows the majority of patients to have minimal insulin requirements post-operatively. With proper patient selection, these outcomes can be achieved.
KeywordsChronic pancreatitis Islet cell auto-transplantation Outcomes Total pancreatectomy
Compliance with Ethics Guidelines
Conflict of Interest
Noaman S. Ali declares that he has no conflict of interest.
R. Matthew Walsh declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 7.••Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214(4):409–24. discussion 424–6. This is the case series from the University of Minnesota, the largest reported with over 400 patients.PubMedCentralPubMedCrossRefGoogle Scholar
- 11.•Walsh RM, Saavedra JR, Lentz G, et al. Improved quality of life following total pancreatectomy and auto-islet transplantation for chronic pancreatitis. J Gastrointest Surg. 2012;16(8):1469–77. This paper highlights the improvement in quality of life and opoid requirements post operatively.Google Scholar
- 13.•Lundberg R, Beilman GJ, Dunn TB, et al. Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential. Am J Transplant. 2013;13(10):2664–71. This highlights the key pre-operative factors that can predict islet cell yield and potential insulin independence post-operatively.PubMedCrossRefGoogle Scholar
- 20.•Balzano G, Maffi P, Nano R, et al. Extending indications for islet autotransplantation in pancreatic surgery. Ann Surg. 2013;258(2):210–8.This paper shows potential utilization for TP-IAT in settings outside of chronic pancreatitis.Google Scholar
- 28.Bhayani NH, Enomoto LM, Miller JL, et al. Morbidity of total pancreatectomy with islet cell auto-transplantation compared to total pancreatectomy alone. HPB (Oxford). 2013.Google Scholar
- 32.•Robertson RP, Lanz KJ, Sutherland DE, et al. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001;50(1):47–50.Shows long term outcomes with insulin independence.Google Scholar